Luo Xiao, Zhang Qi, Chen Hongbo, Hou Kai, Zeng Ning, Wu Yiping
Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Oncol. 2022 May 26;12:907684. doi: 10.3389/fonc.2022.907684. eCollection 2022.
Breast cancer (BC) is the most common malignant tumor in women. There are different risk characteristics and treatment strategies for different subtypes of BC. The tumor microenvironment (TME) is of great significance for understanding the occurrence, development, and metastasis of tumors. The TME plays an important role in all stages of BC metastasis, immune monitoring, immune response avoidance, and drug resistance, and also plays an important role in the diagnosis, prevention, and prognosis of BC. Smart nanosystems have broad development prospect in the regulation of the BC drug delivery based on the response of the TME. In particular, TME-responsive nanoparticles cleverly utilize the abnormal features of BC tissues and cells to achieve targeted transport, stable release, and improved efficacy. We here present a review of the mechanisms underlying the response of the TME to BC to provide potential nanostrategies for future BC treatment.
乳腺癌(BC)是女性中最常见的恶性肿瘤。不同亚型的BC具有不同的风险特征和治疗策略。肿瘤微环境(TME)对于理解肿瘤的发生、发展和转移具有重要意义。TME在BC转移、免疫监测、免疫反应逃避和耐药性的各个阶段都发挥着重要作用,并且在BC的诊断、预防和预后中也起着重要作用。基于TME的响应,智能纳米系统在BC药物递送的调控方面具有广阔的发展前景。特别是,TME响应性纳米颗粒巧妙地利用BC组织和细胞的异常特征来实现靶向运输、稳定释放并提高疗效。我们在此综述TME对BC作出响应的潜在机制,为未来BC治疗提供潜在的纳米策略。